A Gaithersburg drug company has signed another deal to develop and manufacture another drug company's vaccine candidate for COVID-19.

Tagged with: COVID-19 emergent biosolutions inc. Maryland business COVID-19

A Gaithersburg drug company has received $4 million in funding from a nongovernmental organization to develop a COVID-19 vaccine and is teaming with another Gaithersburg drug company for development and manufacturing.

Tagged with: Coalition for Epidemic Preparedness Innovations coronavirus COVID-19 emergent biosolutions inc. Novavax Inc. vaccine

Emergent BioSolutions Inc., a Gaithersburg life sciences firm that makes products to address public health threats received a favorable opinion from a European regulator for its cholera vaccine.

Tagged with: emergent biosolutions inc.

Emergent BioSolutions Inc., a Gaithersburg life sciences firm that makes products to address public health threats, has an agreement with the European Medicines Agency to pursue its proposed development plan for a vaccine candidate.

Tagged with: emergent biosolutions inc. gaithersburg Montgomery County

Emergent BioSolutions Inc., a Gaithersburg life sciences firm that makes products to address public health threats, has been granted an important designation in Europe that could speed development of a vaccine candidate.

Tagged with: emergent biosolutions inc. European Medicines Agency gaithersburg Montgomery County

A Gaithersburg maker of products that address public health threats has received a new federal contract worth about $6.3 million for a treatment for opioid addiction.

Tagged with: emergent biosolutions inc.

A Maryland life sciences company with a focus on public health threats has plans to buy the maker of a nasal spray used to treat people suspected of overdosing on opioids.

Tagged with: emergent biosolutions inc. gaithersburg Montgomery County naloxone opioid crisis

Emergent BioSolutions, a Gaithersburg-based pharmaceutical company that provides infectious disease vaccines for the U.S. government, is about to add cholera and typhoid vaccines to its arsenal. The company announced Thursday that it is spending $270 million cash to acquire PaxVax, ...

Tagged with: emergent biosolutions inc.

The Centers for Disease Control and Prevention has awarded Emergent BioSolutions Inc. a $26 million contract to continue to supply a medical treatment to the government.

Tagged with: CDC emergent biosolutions inc. gaithersburg Montgomery County

Emergent BioSolutions Inc., a biotechnology company in Gaithersburg, had increased revenues and profits in unaudited financial results for its fourth quarter and the year 2017.

Tagged with: emergent biosolutions inc. gaithersburg Montgomery County